Synovus Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,694
Closed -$417K 803
2020
Q4
$417K Buy
2,694
+119
+5% +$18.4K ﹤0.01% 583
2020
Q3
$292K Sell
2,575
-130
-5% -$14.7K ﹤0.01% 605
2020
Q2
$304K Sell
2,705
-3,364
-55% -$378K ﹤0.01% 577
2020
Q1
$559K Buy
6,069
+3,585
+144% +$330K 0.01% 493
2019
Q4
$267K Buy
2,484
+93
+4% +$10K ﹤0.01% 617
2019
Q3
$230K Buy
2,391
+106
+5% +$10.2K ﹤0.01% 630
2019
Q2
$302K Buy
2,285
+83
+4% +$11K ﹤0.01% 539
2019
Q1
$298K Buy
2,202
+1,678
+320% +$227K ﹤0.01% 521
2018
Q4
$52K Buy
524
+65
+14% +$6.45K ﹤0.01% 785
2018
Q3
$63K Buy
459
+353
+333% +$48.5K ﹤0.01% 783
2018
Q2
$13K Hold
106
﹤0.01% 1024
2018
Q1
$12K Sell
106
-2,002
-95% -$227K ﹤0.01% 1013
2017
Q4
$252K Buy
2,108
+61
+3% +$7.29K ﹤0.01% 529
2017
Q3
$290K Sell
2,047
-13,190
-87% -$1.87M 0.01% 484
2017
Q2
$1.85M Sell
15,237
-549
-3% -$66.8K 0.04% 198
2017
Q1
$1.91M Buy
15,786
+701
+5% +$84.9K 0.04% 180
2016
Q4
$1.85M Sell
15,085
-1,024
-6% -$125K 0.04% 177
2016
Q3
$1.98M Buy
16,109
+442
+3% +$54.2K 0.05% 166
2016
Q2
$1.83M Buy
15,667
+4,421
+39% +$517K 0.04% 177
2016
Q1
$1.57M Buy
11,246
+10,420
+1,262% +$1.45M 0.04% 193
2015
Q4
$157K Buy
826
+815
+7,409% +$155K ﹤0.01% 483
2015
Q3
$2K Sell
11
-38
-78% -$6.91K ﹤0.01% 928
2015
Q2
$9K Sell
49
-94
-66% -$17.3K ﹤0.01% 856
2015
Q1
$24K Hold
143
﹤0.01% 741
2014
Q4
$26K Hold
143
﹤0.01% 729
2014
Q3
$24K Hold
143
﹤0.01% 714
2014
Q2
$23K Hold
143
﹤0.01% 688
2014
Q1
$21K Buy
+143
New +$21K ﹤0.01% 698